Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2013

Levine AM, Noy A, Lee JY, Tam W, Ramos JC, Henry DH, et al. Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. J Clin Oncol. 2013;31(1):58-64.

Rossi A, Mark T, Jayabalan D, Christos P, Zafar F, Pekle K, et al. BiRd (clarithromycin, lenalidomide, dexamethasone): an update on long-term lenalidomide therapy in previously untreated patients with multiple myeloma. Blood. 2013;121(11):1982-5.

Westblade LF, Chamberland RR, MacCannell D, Collins R, Dubberke ER, W Dunne M, et al. Development and evaluation of a novel, semiautomated Clostridium difficile typing platform. J Clin Microbiol. 2013;51(2):621-4.

Kopycinska J, Kempińska-Podhorodecka A, Haas T, Elias E, DePinho RA, Paik J, et al. Activation of FoxO3a/Bim axis in patients with Primary Biliary Cirrhosis. Liver Int. 2013;33(2):231-8.

Malatesta M, Peschiaroli A, Memmi EM, Zhang J, Antonov A, Green DR, et al. The Cul4A-DDB1 E3 ubiquitin ligase complex represses p73 transcriptional activity. Oncogene. 2013;32(39):4721-6.

Maniar KP, Ronnett BM, Vang R, Yemelyanova A. Coexisting high-grade vulvar intraepithelial neoplasia (VIN) and condyloma acuminatum: independent lesions due to different HPV types occurring in immunocompromised patients. Am J Surg Pathol. 2013;37(1):53-60.

Ma L, Tao Y, Duran A, Llado V, Galvez A, Barger JF, et al. Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis. Cell. 2013;152(3):599-611.

Petrocca F, Altschuler G, Tan SM, Mendillo ML, Yan H, D Jerry J, et al. A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cells. Cancer Cell. 2013;24(2):182-96.

Lunardi A, Ala U, Epping MT, Salmena L, Clohessy JG, Webster KA, et al. A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. Nat Genet. 2013;45(7):747-55.

Yost AJ, Shevchuk OO, Gooch R, Gusscott S, You MJ, Ince TA, et al. Defined, serum-free conditions for in vitro culture of primary human T-ALL blasts. Leukemia. 2013;27(6):1437-40.